Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Harputoglu, H"'
Central nervous system (CNS) metastasis is a rare event in the course of late stage epithelial ovarian cancer (EOC); however its incidence is increasing in parallel with prolonged survival of patients. Objective: The authors assessed the clinical par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::129c4b58e5475ed96693b6e52181ecac
https://hdl.handle.net/11499/9312
https://hdl.handle.net/11499/9312
Autor:
Seber, S, Turkmen, E, Harputoglu, H, Yesil, H, Arpaci, E, Menekse, S, Pilanci, K, Oruc, Z, Taskoylu, BY, Gumusay, O, Aksoy, A, Karaagac, M, Ozarslan, E, Yetisyigit, T
Central nervous system (CNS) metastasis is a rare event in the course of late stage epithelial ovarian cancer (EOC); however its incidence is increasing in parallel with prolonged survival of patients. Objective: The authors assessed the clinical par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::4e07a854473adf2d4af5320ab4915bb1
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/16187
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/16187
Autor:
Seber, S, Turkmen, E, Harputoglu, H, Yesil, H, Arpaci, E, Menekse, S, Pilanci, K, Oruç, Zeynep, Taskoylu, BY, Gumusay, O, Aksoy, A, Karaagac, M, Ozarslan, E, Yetisyigit, T
Central nervous system (CNS) metastasis is a rare event in the course of late stage epithelial ovarian cancer (EOC); however its incidence is increasing in parallel with prolonged survival of patients. Objective: The authors assessed the clinical par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::de6ae6384357cd39241703f7f8694b53
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/9312
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/9312
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Inal, A, Akman, T, Yaman, S, Ozturk, SC, Geredeli, C, Bilici, M, Inanc, M, Harputoglu, H, Demirci, U, Balakan, O, Cinkir, HY, Alici, S, Colak, D, Sonmez, OU, Goksel, G, Dogu, GG, Engin, H, Unal, OU, Tamozlu, T, Buyukberber, S, Boruban, CM, Isikdogan, A
There is very little information about breast cancer characteristics, treatment choices, and survival among elderly patients. The purpose of this multicenter retrospective study was to examine the clinical, pathologic, and biologic characteristics of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::35260538d9fc7815d353f2629d603762
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/22141
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/22141
Autor:
Inal, A, Akman, T, Yaman, S, Ozturk, SD, Geredeli, C, Bilici, M, Inanc, M, Harputoglu, H, Demirci, U, Balakan, O, Cinkir, HY, Alici, S, Sonmez, OU, Goksel, G, Dogu, GG, Unal, OU, Tamozlu, T, Buyukberber, S, Boruban, CM, Isikdogan, A
Purpose: The extra benefit of adding chemotherapy to effective endocrine therapy (ET) has not been clearly or consistently identified in patients older than 70 years with estrogen receptor (ER) positive and node positive breast cancer. The aim of thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::6256136d6d01af24f0728ed41e424dc7
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/21563
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/21563
Autor:
Dikiltas, M., Helvaci, K., Geredeli, C., Gumus, M., Kucukoner, M., Inal, A., Kos, F. T., Ozkan, M., Uncu, D., Buyukberber, S., Ozdemir, N., Goksel, G., Harputoglu, H., Durnali, A. G., Kaplan, M. A., Balakan, O., Dane, F., Benekli, M., Isikdogan, A., ÜNEK, İLKAY TUĞBA, Algin, E., Yildiz, R., Colak, D., ELKIRAN, EMİN TAMER
Publikováno v:
Neoplasma. 59(3)
The majority of patients with pancreatic cancer is of advanced disease. Several randomized Phase II and III trials suggest that the combination of gemcitabine and cisplatin (GemCis) response rates were higher than Gemcitabine (Gem) alone, however the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6e9dd7202562454f935b89e06b3a70f0
https://pubmed.ncbi.nlm.nih.gov/22329849
https://pubmed.ncbi.nlm.nih.gov/22329849
Autor:
Inal, A., Kos, F. T., Algin, E., Yildiz, R., Berk, V., Unek, I. Tugba, Colak, D., Kucukoner, M., Elkiran, E. Tamer, Helvaci, K., Geredeli, C., Dane, F., Balakan, O., Ali İnal, Durnali, A. Gok, Harputoglu, H., Goksel, G., Ozdemir, N., Buyukberber, S., Gumus, M., Ozkan, M., Benekli, M., Isikdogan, A.
Publikováno v:
Scopus-Elsevier
Web of Science
Web of Science
Purpose: The majority of patients with pancreatic cancer present with advanced disease. Systemic chemotherapy for patients with pancreatic cancer has limited impact on overall survival (OS). Patients eligible for chemotherapy should be selected caref
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::4c569887b4e0f92c59a824c31d709eb8
https://avesis.gazi.edu.tr/publication/details/c2ced8e4-a4c2-424c-88ff-7ae48abcd085/oai
https://avesis.gazi.edu.tr/publication/details/c2ced8e4-a4c2-424c-88ff-7ae48abcd085/oai
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.